Видео ютуба по тегу Enzalutamide

Enzalutamide for Biochemically Recurrent Prostate Cancer | NEJM
Enzalutamide for Biochemically Recurrent Prostate Cancer | NEJM
Patient Information Video Enzalutamide
Patient Information Video Enzalutamide
Live long and PROSPER: enzalutamide for nmCRPC
Live long and PROSPER: enzalutamide for nmCRPC
Enzalutamide Approved for Prostate Cancer With Biochemical Recurrence: Stephen Freedland, MD
Enzalutamide Approved for Prostate Cancer With Biochemical Recurrence: Stephen Freedland, MD
ENZAMET: Enzalutamide for metastatic prostate cancer
ENZAMET: Enzalutamide for metastatic prostate cancer
Dr. Chi on Abiraterone Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer
Dr. Chi on Abiraterone Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer
Apalutamide vs Enzalutamide: Insights on Real-World Survival Benefits and Clinical Implications
Apalutamide vs Enzalutamide: Insights on Real-World Survival Benefits and Clinical Implications
Dr. Agarwal on the Safety Profile of Enzalutamide/Talazoparib in mCRPC
Dr. Agarwal on the Safety Profile of Enzalutamide/Talazoparib in mCRPC
Dr. Dreicer on Abiraterone and Enzalutamide in Prostate Cancer
Dr. Dreicer on Abiraterone and Enzalutamide in Prostate Cancer
Dr. Shore on the Enzalutamide Mechanism of Action
Dr. Shore on the Enzalutamide Mechanism of Action
Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer
Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer
Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC
Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC
Enzalutamide (XTANDI) for Prostate Cancer: Benefits, Side Effects, and 2024 Safety Update
Enzalutamide (XTANDI) for Prostate Cancer: Benefits, Side Effects, and 2024 Safety Update
TERRAIN: Enzalutamide versus bicalutamide for metastatic prostate cancer
TERRAIN: Enzalutamide versus bicalutamide for metastatic prostate cancer
Enzalutamide? Abiraterone? Neither?
Enzalutamide? Abiraterone? Neither?
Dr. Bradley on Adverse Events Associated With Enzalutamide and Apalutamide in Prostate Cancer
Dr. Bradley on Adverse Events Associated With Enzalutamide and Apalutamide in Prostate Cancer
Dr. Mary-Ellen Taplin on the Mechanism of Action of Enzalutamide (MDV3100)
Dr. Mary-Ellen Taplin on the Mechanism of Action of Enzalutamide (MDV3100)
Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...
Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...